Click for best price
Hepatitis B Virus HBV Market Size, Share 2023
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Virus (HBV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Virus (HBV). This report contains market size and forecasts of Hepatitis B Virus (HBV) in global, including the following market information:
Global Hepatitis B Virus (HBV) Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Hepatitis B Virus (HBV) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.
We surveyed the Hepatitis B Virus (HBV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Virus (HBV) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, by Type, 2022 (%)
Therapeutics
Vaccine
Global Hepatitis B Virus (HBV) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Hepatitis B Virus (HBV) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Virus (HBV) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hepatitis B Virus (HBV) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis B Virus (HBV), market overview.
Chapter 2: Global Hepatitis B Virus (HBV) market size in revenue.
Chapter 3: Detailed analysis of Hepatitis B Virus (HBV) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis B Virus (HBV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Report Attributes |
Report Details |
Report Title |
Hepatitis B Virus (HBV) Market, Global Outlook and Forecast 2023-2030 |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2022 |
Forecast Year |
2030 |
Number of Pages |
66 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Virus (HBV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Virus (HBV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Virus (HBV) Overall Market Size
2.1 Global Hepatitis B Virus (HBV) Market Size: 2022 VS 2030
2.2 Global Hepatitis B Virus (HBV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B Virus (HBV) Players in Global Market
3.2 Top Global Hepatitis B Virus (HBV) Companies Ranked by Revenue
3.3 Global Hepatitis B Virus (HBV) Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Virus (HBV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hepatitis B Virus (HBV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Virus (HBV) Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B Virus (HBV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Virus (HBV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B Virus (HBV) Market Size Markets, 2022 & 2030
4.1.2 Therapeutics
4.1.3 Vaccine
4.2 By Type - Global Hepatitis B Virus (HBV) Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Virus (HBV) Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis B Virus (HBV) Revenue, 2024-2030
4.2.3 By Type - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Virus (HBV) Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.2 By Application - Global Hepatitis B Virus (HBV) Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Virus (HBV) Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis B Virus (HBV) Revenue, 2024-2030
5.2.3 By Application - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Hepatitis B Virus (HBV) Market Size, 2022 & 2030
6.2 By Region - Global Hepatitis B Virus (HBV) Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Virus (HBV) Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis B Virus (HBV) Revenue, 2024-2030
6.2.3 By Region - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Hepatitis B Virus (HBV) Revenue, 2018-2030
6.3.2 US Hepatitis B Virus (HBV) Market Size, 2018-2030
6.3.3 Canada Hepatitis B Virus (HBV) Market Size, 2018-2030
6.3.4 Mexico Hepatitis B Virus (HBV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Hepatitis B Virus (HBV) Revenue, 2018-2030
6.4.2 Germany Hepatitis B Virus (HBV) Market Size, 2018-2030
6.4.3 France Hepatitis B Virus (HBV) Market Size, 2018-2030
6.4.4 U.K. Hepatitis B Virus (HBV) Market Size, 2018-2030
6.4.5 Italy Hepatitis B Virus (HBV) Market Size, 2018-2030
6.4.6 Russia Hepatitis B Virus (HBV) Market Size, 2018-2030
6.4.7 Nordic Countries Hepatitis B Virus (HBV) Market Size, 2018-2030
6.4.8 Benelux Hepatitis B Virus (HBV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Hepatitis B Virus (HBV) Revenue, 2018-2030
6.5.2 China Hepatitis B Virus (HBV) Market Size, 2018-2030
6.5.3 Japan Hepatitis B Virus (HBV) Market Size, 2018-2030
6.5.4 South Korea Hepatitis B Virus (HBV) Market Size, 2018-2030
6.5.5 Southeast Asia Hepatitis B Virus (HBV) Market Size, 2018-2030
6.5.6 India Hepatitis B Virus (HBV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Hepatitis B Virus (HBV) Revenue, 2018-2030
6.6.2 Brazil Hepatitis B Virus (HBV) Market Size, 2018-2030
6.6.3 Argentina Hepatitis B Virus (HBV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue, 2018-2030
6.7.2 Turkey Hepatitis B Virus (HBV) Market Size, 2018-2030
6.7.3 Israel Hepatitis B Virus (HBV) Market Size, 2018-2030
6.7.4 Saudi Arabia Hepatitis B Virus (HBV) Market Size, 2018-2030
6.7.5 UAE Hepatitis B Virus (HBV) Market Size, 2018-2030
7 Hepatitis B Virus (HBV) Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Hepatitis B Virus (HBV) Major Product Offerings
7.1.4 Merck Hepatitis B Virus (HBV) Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Hepatitis B Virus (HBV) Major Product Offerings
7.2.4 Gilead Sciences Hepatitis B Virus (HBV) Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Hepatitis B Virus (HBV) Major Product Offerings
7.3.4 Novartis Hepatitis B Virus (HBV) Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Hepatitis B Virus (HBV) Major Product Offerings
7.4.4 GlaxoSmithKline Hepatitis B Virus (HBV) Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Hoffmann
7.5.1 Hoffmann Company Summary
7.5.2 Hoffmann Business Overview
7.5.3 Hoffmann Hepatitis B Virus (HBV) Major Product Offerings
7.5.4 Hoffmann Hepatitis B Virus (HBV) Revenue in Global Market (2018-2023)
7.5.5 Hoffmann Key News & Latest Developments
7.6 La Roche
7.6.1 La Roche Company Summary
7.6.2 La Roche Business Overview
7.6.3 La Roche Hepatitis B Virus (HBV) Major Product Offerings
7.6.4 La Roche Hepatitis B Virus (HBV) Revenue in Global Market (2018-2023)
7.6.5 La Roche Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Hepatitis B Virus (HBV) Major Product Offerings
7.7.4 Bristol-Myers Squibb Hepatitis B Virus (HBV) Revenue in Global Market (2018-2023)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis B Virus (HBV) Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Virus (HBV) Market Drivers in Global Market
Table 3. Hepatitis B Virus (HBV) Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Virus (HBV) in Global Market
Table 5. Top Hepatitis B Virus (HBV) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hepatitis B Virus (HBV) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hepatitis B Virus (HBV) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hepatitis B Virus (HBV) Product Type
Table 9. List of Global Tier 1 Hepatitis B Virus (HBV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Virus (HBV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hepatitis B Virus (HBV) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Hepatitis B Virus (HBV) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hepatitis B Virus (HBV) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2024-2030
Table 30. Merck Company Summary
Table 31. Merck Hepatitis B Virus (HBV) Product Offerings
Table 32. Merck Hepatitis B Virus (HBV) Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Hepatitis B Virus (HBV) Product Offerings
Table 36. Gilead Sciences Hepatitis B Virus (HBV) Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Hepatitis B Virus (HBV) Product Offerings
Table 40. Novartis Hepatitis B Virus (HBV) Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Hepatitis B Virus (HBV) Product Offerings
Table 44. GlaxoSmithKline Hepatitis B Virus (HBV) Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Hoffmann Company Summary
Table 47. Hoffmann Hepatitis B Virus (HBV) Product Offerings
Table 48. Hoffmann Hepatitis B Virus (HBV) Revenue (US$, Mn) & (2018-2023)
Table 49. Hoffmann Key News & Latest Developments
Table 50. La Roche Company Summary
Table 51. La Roche Hepatitis B Virus (HBV) Product Offerings
Table 52. La Roche Hepatitis B Virus (HBV) Revenue (US$, Mn) & (2018-2023)
Table 53. La Roche Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Hepatitis B Virus (HBV) Product Offerings
Table 56. Bristol-Myers Squibb Hepatitis B Virus (HBV) Revenue (US$, Mn) & (2018-2023)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
List of Figures
Figure 1. Hepatitis B Virus (HBV) Segment by Type in 2022
Figure 2. Hepatitis B Virus (HBV) Segment by Application in 2022
Figure 3. Global Hepatitis B Virus (HBV) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Virus (HBV) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hepatitis B Virus (HBV) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Virus (HBV) Revenue in 2022
Figure 8. By Type - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 16. US Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 20. Germany Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 21. France Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 28. China Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 32. India Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 34. Brazil Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Hepatitis B Virus (HBV) Revenue Market Share, 2018-2030
Figure 37. Turkey Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Hepatitis B Virus (HBV) Revenue, (US$, Mn), 2018-2030
Figure 41. Merck Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hoffmann Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. La Roche Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bristol-Myers Squibb Hepatitis B Virus (HBV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)